ShahzadRazaMD

PubMed

• 172 citations
  Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.
  Maria-Victoria Mateos, Hilary Blacklock, Fredrik Schjesvold, Albert Oriol, David Simpson
  The Lancet. Haematology. 2019-07-18
• 6 citations
  Systemic AL amyloidosis: current approach and future direction.
  Maroun Bou Zerdan, Lewis Nasr, Farhan Khalid, Sabine Allam, Youssef Bouferraa
  Oncotarget. 2023-04-26
• 4 citations
  Timing of Toxicities and Non-Relapse Mortality Following CAR T Therapy in Myeloma.
  William Wesson, Danai Dima, Nahid Suleman, Md Saiful Islam Saif, Carine Tabak
  Transplantation and Cellular Therapy. 2024-09-01

Journal Articles

• Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review  
  Razwana Khanam, Beth Faiman, Saba Batool, Mohammed Musa Najmuddin 4, Rana Usman 5 , Kiran Kuriakose 6, Arooj Ahmed 7, Mohammad Ebad Ur Rehman 8, Zinath Roksana 9 , Zai..., Journal of Clinical Medicine, 8/25/2023
• Systemic AL amyloidosis: current approach and future direction  
  Maroun Bou Zerdan1, Lewis Nasr2, Farhan Khalid3, Sabine Allam4, Youssef Bouferraa5, Saba Batool6, Muhammad Tayyeb7, Shubham Adroja8, Mahinbanu Mammadii1, Faiz Anwer9, ..., Oncotarget. 2023; 14:384-394, 4/26/2023
• Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice  
  Danai Dima 1,*ORCID, Fauzia Ullah 1, Sandra Mazzoni 1ORCID, Louis Williams 1, Beth Faiman 1, Austin Kurkowski 2, Chakra Chaulagain 3ORCID, Shahzad Raza 1ORCID, Christy..., Cancers 2023, 15(7), 2160
• Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia  
  Suparna Nanua, Furha Cossor, Shahzad Raza, eJHaem, 11/25/2020
• Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia  
  Nanua Suparna, Shahzad Raza, eJHaem, 11/25/2020
• Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma  
  Siyang Leng , Divaya Bhutani, Shahzad Raza, Amer Assal, Samuel Pan, Jianhua Hu, Alexander Wei, Markus Mapara & Suzanne Lentzsch, Blood Cancer Journal, 2/3/2020
• A Prospective Study on Red Blood Cell Transfusion Related Hyperkalemia in Critically Ill Patients  
  Raza S1, Ali Baig M2, Chang C3, Dabas R3, Akhtar M3, Khan A3, Nemani K3, Alani R3, Majumder O3, Gazizova N3, Biswas S3, Patel P3, Al-Hilli JA3, Shad Y3, Berger BJ3, Za..., J Clin Med Res., 6/15/2015
• Join now to see all

Books/Book Chapters

• Current treatment options in the management of locally advanced head and neck cancers, Recent patents on anti- cancer drug discovery 
  Chapter: Topics in Anti-Cancer Research 
  Page 334 - 367Raza S, Khan A, Khan M, Al-Hilli J, Baig M, Aksoy T, Kalavar M, Ramasubbaiah REditors: ISBN: 978- 1- 60805-612-5. Bentham Science publishers2012
• Small Bowel Adenocarcinoma 
  Chapter: The research and biology of cancer 
  Poddar N, Singh A, Raza S, Kalavar MEditors: ISBN: 978-1-922227-23-2.I Concept Press2012

Abstracts/Posters

• Disparities in multiple myeloma : A global perspective on drug toxicity trends
  Majid Jaberi- Douraki, Xuan Xu, Beth Faiman, Gerald Wyckoff, Jim Riviere, Jack Khouri, Sandra Ann Mazzoni, Remya Ampadi Ramachandran, Nuwan Millagaha Gadara, Mobina Go..., 2023 Annual American Society of Clinical Oncology Oral Poster Discussion, J Clin Oncol 41, 2023 ( suppl 16; abstr 8015), 6/5/2023
• Identification of genes encoding targets associated with adverse events in multiple myeloma
  Xuan Xu, Shahzad Raza, Nuwan Millagaha Gadara, Remya Ampadi Ramachandran, Jim Riviere, Mobina Golmohammadi, Gerald Wyckoff, Beth Faiman, Faiz Anwer, Ashiq Masood, Jack..., 2023 Annual ASCO Meeting, Poster Presentation, J Clin Oncol 41, 2023 (suppl 16; abstr 1556), 6/5/2023
• Disparities in multiple myeloma: A global perspective on drug toxicity trends.
  Majid Jaberi-Douraki, Xuan Xu, Beth Faiman, Gerald Wyckoff, Jim Riviere, Jack Khouri, Sandra Ann Mazzoni, Remya Ampadi Ramachandran, Nuwan Millagaha Gadara, Mobina Gol..., American Society of Clinical Psychology Oncology 2023, Chicago, 6/5/2023
• A novel risk assessment metric for antimyeloma therapies and drug interactions
  Xuan Xu, Majid Jaberi-Douraki, Faiz Anwer, Beth Faiman, Louis Williams, Sandra Ann Mazzoni, Jack Khouri, Jason Neil Valent, Remya Ampadi Ramachandran, Jim Riviere, Nuw..., 2023 Annual ASCO Meeting, 6/2023
• Echocardiographic Changes of Carfilzomib Therapy in Multiple Myeloma Patients
  Waled Bahaj, Anas Albawaliz, MD, Madeline E Begemann, RN, Anuj Shrestha, MD, Brett Sperry, MD, Shahzad Raza, MD, American Society of Hematology, 11/5/2020
• Long-term time trends in incidence, survival and mortality of Hodgkin lymphoma in the United States: A surveillance, epidemiology, and end results (SEER) database stud...
  Samia Asif, Shahzad Raza, Journal of Clinical Oncology, 6/2019
• Updated Results of a Phase 2 Study of Bendamustine in Combination with Dexamethasone (Ben/Dex) in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis
  Suzanne Lentzsch, MD, PhD1, Raymond L. Comenzo, MD2, Jeffrey A Zonder, MD3, Keren Osman, MD4*, Miao Susanna5*, Daniel Backenroth5*, Daniel Otap5*, Wei-Yann Tsai6*, Siv..., American Society of Haematology, Orlando, Florida, 12/6/2015
• Results of Phase I Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients with AL Amyloidosis
  Arielle L Langer, MD, MPH1*, Susanna Miao2*, Markus Mapara, MD, PhD3, Jai Radhakrishnan, MD4*, Mathew S. Maurer, MD5*, Shahzad Raza, MD6*, John G. Mears, MD3, Alan Sol..., American Society of Haematology, Orlando, Florida, 12/5/2015
• Tension Pneumocephalus undiagnosed entity in nasopharyngeal carcinoma
  Manandhar N, Raza S, Ramasubbaiah R, Doll D, American College of Physician, Ozark, Missouri, 10/10/2014
• Survival disparities and trend of head and neck cancer in the United States: A surveillance, epidemiology, and end results (SEER) database study 1973-2010
  Raza S, Kale G, Lata A, Hossain, J Clin Oncol 32:5s, 2014 (suppl; abstr 6066), American Society of Clinical Oncology, 6/1/2014
• Correlation of high metabolic activity on 18F-FDG PET-CT at diagnosis with early relapse and mortality for patients with primary lung cancer
  Raza S, Firwana B, Wang Z, Yousef I, Shortridge J, Kirkland R, Kale G, Naidzionak U, Bobba R, Doll D, . J Clin Oncol 32, 2014 (suppl; abstr e19088), 6/1/2014
• Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall su...
  M. L. Gruber, S. Raza, D. Gruber, A. Narayana, Journal of Clinical Oncol 2009; 27:15s Abstract no 2017, American Society of Clinical Oncology, 6/1/2009
• Outcomes of stereotactic radiosurgery in the management of brain metastasis in patients with HER2 positive metastatic breast cancer
  Raza S, Narayana A, Morsi A, Parker E, Rush S, Novik Y, Cancer Research: 2009; 69 (24): S3., San Antonio Breast Cancer Conference, 2009
• Anti-angiogenic therapy in recurrent high grade glioma: Impact on local control and survival
  Narayana A, Raza S , Golfinos J. G, Johnson G, Knopp A, E, Zagzag D, Fischer I, Gruber LM, J Clin Oncol 2008; 26 (15): 621s, American Society of Clinical Oncology, 2008
• Change in Pattern of Relapse Following Anti-angiogenic Therapy in High Grade Glioma
  Narayana A, Golfinos G. J, Raza S, Knopp E, Medabalmi P, Parker E, Zagzag D, Gruber LM., .Int J Radiat Oncol Biol Phys, 2008; 72(1): S11, American Society for Therapeutic Radiology & Oncology, 2008
• Join now to see all